Which startups have raised the most funding in the healthcare AI market?

The healthcare AI market has attracted tens of billions of dollars across drug discovery, clinical documentation, medical imaging, diagnostics, hospital workflows and other healthcare applications.

To make this market easier to follow, we maintain a ranking of the most funded healthcare AI startups and update the list every month as companies announce new financing rounds.

The ranking focuses on cumulative funding, which helps show which healthcare AI companies have attracted the deepest pools of investor capital over time.

And if you want to better understand this new industry, you can download our pitch covering the healthcare AI market.

As this chart shows, and as featured in our healthcare AI market deck, search interest in healthcare AI has grown rapidly

A few word about our methodology

As you can see, we built a database that ranks startups in the healthcare AI market based on their total cumulative fundraising. To create this ranking, we reviewed many sources and cross-checked information across multiple places.

Whenever possible, we prioritized official company communications, since they are the most reliable source for funding amounts. When those were not available, we relied on reputable industry sources such as TechCrunch, Crunchbase, Financial Times or Forbes (to name a few).

We excluded random blogs, unverified websites, and any sources that could not be validated.

When funding rounds were announced in other currencies such as euros, Swiss francs, Singapore dollars, Australian dollars, or rupees, we converted them into approximate USD equivalents for consistency.

Healthcare AI includes several different business models, including AI drug discovery, clinical documentation, medical imaging, diagnostics, healthcare workflow automation, precision medicine and AI-enabled clinical research. We focused on companies where artificial intelligence is an important part of the product or technology platform.

Sometimes different sources report slightly different numbers, or the exact round size is not fully disclosed. In those cases, we flag the uncertainty and assign a confidence label to each startup, visible in the last column.

Here is what they mean.

Full confidence: The company’s equity fundraising history can be reconstructed completely from public sources. The rounds, dates, amounts, and key investors are clearly identified, with no meaningful gaps.

Strong confidence: The fundraising history is largely complete and reliable. There may be a small missing detail, such as incomplete investor information or a minor round with limited data, but the overall record is clear.

Partial confidence: The main fundraising rounds can be identified, but the record is incomplete or somewhat mixed. Some rounds may be missing or certain funding events may be difficult to separate clearly.

Low confidence: Public information is too limited, inconsistent, or ambiguous to reliably reconstruct the company’s equity fundraising history.

When the confidence level is too low, we take a conservative approach and exclude the company from the ranking. We don’t want to include data that cannot be reliably verified.

This reflects how we conduct all our research, including the work behind our report covering the healthcare AI market.

In a world where LLMs hallucinate and unreliable information is everywhere, our goal is simple: provide data you can trust.

If you want the full detail on a specific calculation, feel free to contact us and we will gladly explain.

Finally, know that we update the dataset once per month, so come back here if you need fresh information.

This chart, featured in our healthcare AI market deck, looks at Tempus AI’s strategy in healthcare AI

Who is the author of this content?

NEW MARKET PITCH TEAM

We track new markets so founders and investors can move faster

We build living “market pitch” documents for emerging markets: from AI to synthetic biology and new proteins. Instead of digging through outdated PDFs, random blog posts, and hallucinated LLM answers, our clients get a clean, visual, always-updated view of what’s really happening. We map the key players, deals, regulations, metrics and signals that matter so you can decide faster whether a market is worth your time. Want to know more? Check out our about page. You can also follow us on Instagram or on Facebook.